Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Phio Pharmaceuticals Corp (NASDAQ: PHIO) was $1.63 for the day, down -12.37% from the previous closing price of $1.86. In other words, the price has decreased by -$12.37 from its previous closing price. On the day, 2.28 million shares were traded. PHIO stock price reached its highest trading level at $1.79 during the session, while it also had its lowest trading level at $1.6.
Ratios:
Our analysis of PHIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.36 and its Current Ratio is at 9.36. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 05, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 10 ’25 when Bitterman Robert J bought 2,000 shares for $2.42 per share. The transaction valued at 4,840 led to the insider holds 27,149 shares of the business.
Ferrara Robert L bought 2,500 shares of PHIO for $6,050 on Jun 10 ’25. The Director now owns 15,666 shares after completing the transaction at $2.42 per share. On Jun 09 ’25, another insider, Bitterman Robert J, who serves as the Chairman, Pres & CEO of the company, bought 1,500 shares for $2.75 each. As a result, the insider paid 4,125 and bolstered with 25,149 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHIO now has a Market Capitalization of 9334602 and an Enterprise Value of -1440397.
Stock Price History:
The Beta on a monthly basis for PHIO is 0.89, which has changed by -0.42944783 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, PHIO has reached a high of $9.79, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -25.06%, while the 200-Day Moving Average is calculated to be -19.88%.
Shares Statistics:
PHIO traded an average of 2.62M shares per day over the past three months and 16253250 shares per day over the past ten days. A total of 5.73M shares are outstanding, with a floating share count of 4.86M. Insiders hold about 15.19% of the company’s shares, while institutions hold 4.47% stake in the company. Shares short for PHIO as of 1760486400 were 270688 with a Short Ratio of 0.10, compared to 1757894400 on 262234. Therefore, it implies a Short% of Shares Outstanding of 270688 and a Short% of Float of 4.760000000000001.
Earnings Estimates
The performance of Phio Pharmaceuticals Corp (PHIO) in the stock market is under the watchful eye of 1 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.47 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.77 and -$1.77 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.26, with 1.0 analysts recommending between -$1.26 and -$1.26.
